2017
DOI: 10.1177/1740774516688860
|View full text |Cite
|
Sign up to set email alerts
|

Building trust and diversity in patient-centered oncology clinical trials: An integrated model

Abstract: The Integrated Model of Trust offers a novel framework to interrogate the process by which diverse populations and clinical trial teams build trust. To our knowledge, this is the first model of trust-building in clinical trials that frames trust development through integrated clinical and business perspectives. By focusing on the process, rather than outcomes of trust-building diverse trial participants, clinical trials teams, participants, and cancer centers may be able to better understand, measure, and mana… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
24
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 22 publications
(25 citation statements)
references
References 52 publications
0
24
0
Order By: Relevance
“…The model views interpersonal trust as a changeable construct over time that involves development of the relationship, not a static trait (20). The strength of bonding and motives of linking both parties in the relationship develop from a lower base of trust into higher bases (43). In general, however, the concept of transformation in trust is found rarely from the literature in healthcare contexts, let alone the subfield of measuring trust.…”
Section: Resultsmentioning
confidence: 99%
“…The model views interpersonal trust as a changeable construct over time that involves development of the relationship, not a static trait (20). The strength of bonding and motives of linking both parties in the relationship develop from a lower base of trust into higher bases (43). In general, however, the concept of transformation in trust is found rarely from the literature in healthcare contexts, let alone the subfield of measuring trust.…”
Section: Resultsmentioning
confidence: 99%
“…For parents who have mistrust in medical researchers, particularly African American parents, they should be provided the following information: (1) details on the medical researcher and their role in the research process; (2) the benefits of their child participation in the clinical trial, (benefits to their child and other children); and (3) the risks of participation in medical research (including disruptions to their daily routine) and assurance that their child will not be treated as a guinea pig. Based on previous literature (Holzer, Ellis, & Merritt, 2014;Hurd et al 2017;McDavitt et al, 2016), intervention strategies that could be used to provide this information include application of community engaged approaches, message tailoring, and use of testimonials. These communication strategies are key to building trust among underrepresented populations in research, and could assist in building trust between parents and researchers.…”
Section: Discussionmentioning
confidence: 99%
“…An extremely robust and culturally confident team was engaged in PREVAIL to address social fears and stigma. Building trust would be critical, as noted in Hurd et al, “Trust is the cornerstone of clinical trial recruitment and retention.’ [ 4 ].…”
Section: The Myths and The Challengesmentioning
confidence: 99%